Excision of the deep fascia does not improve the outcome of patients with cutaneous melanomas thicker than 2 millimeters, according to a study published the December issue of the British Journal of Dermatology.
MRV Research
Ipilimumab demonstrates long-term survival benefit in advanced melanoma
Some patients with advanced melanoma treated with ipilimumab continued to derive a survival benefit at least 5 years after treatment, according to study results.
Melanoma: Scientists find new link between pigment production and mitochondrial function
A new research report published in the January 2015 issue of the FASEB Journal helps explain what goes wrong to when someone gets skin cancer and the relationship between changing skin pigment and the cancer itself. In particular, this research shows that there is a direct link between changes in mitochondrial function and melanin production in cancerous skin cells. This link may also serve as a viable drug target for the disease.
Pill hope for skin cancer patients
Advanced skin cancer patients in the Westcountry – where rates are double the England average – could benefit from a revolutionary new pill to be trialled for people with resistant disease.